Cite
HARVARD Citation
Eichenauer, D. et al. (n.d.). Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. Lancet oncology. 18 (12), pp. 1680-1687. [Online].